TOKYO -- Swiss pharmaceutical giant Roche plans to continue investing in major markets including the U.S. and Japan despite President Donald Trump's order to lower drug prices, CEO Thomas Schinecker told Nikkei recently, saying that innovation is necessary to reduce costs.
Pharmaceuticals
Drugmaker Roche's global investments crucial to cutting costs: CEO
Subsidiary Chugai's autonomy helps Japan firm innovate, Schinecker says
Cutting innovation will not reduce costs, Roche CEO Thomas Schinecker said. (Photo by Marina Inoue)
Read Next
Latest on Pharmaceuticals
